BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 5707926)

  • 1. [Anxiety, upbringing and psychopharmaca. Biopsychological observations].
    Arnfred AH
    Ugeskr Laeger; 1968 Nov; 130(48):2065-7. PubMed ID: 5707926
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-anxiety drugs in neurotic outpatients.
    Rickels K
    Curr Psychiatr Ther; 1967; 7():118-29. PubMed ID: 4860296
    [No Abstract]   [Full Text] [Related]  

  • 3. Prazepam in the treatment of anxiety and tension: a clinical study of a new benzodiazepine derivative.
    Kingstone E; Villeneuve A; Kossatz I
    Curr Ther Res Clin Exp; 1966 Apr; 8(4):159-63. PubMed ID: 4956321
    [No Abstract]   [Full Text] [Related]  

  • 4. NC 123 in neuroses with depressive and anxiety symptomatology.
    Zapletálek M; Hajcman L; Capáková L
    Act Nerv Super (Praha); 1967 Nov; 9(4):366-8. PubMed ID: 4889064
    [No Abstract]   [Full Text] [Related]  

  • 5. [Psychopharmacologic therapy of neuroses. The problem of personality and its influence on the therapeutic results].
    Barcia D; Martínez Carrillo JA; Morales JM; Agüero A
    Actas Luso Esp Neurol Psiquiatr; 1970 Jan; 29(1):17-38. PubMed ID: 5482847
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drug therapy of child behavior disorders].
    Corboz RJ
    Wien Med Wochenschr; 1969 Jul; 119(30):540-7. PubMed ID: 5351661
    [No Abstract]   [Full Text] [Related]  

  • 7. [Double-blind study of the use of Nobrium in ambulatory therapy].
    Pasini E
    Riv Sper Freniatr Med Leg Alien Ment; 1970 Jun; 94(3):726-55. PubMed ID: 5517401
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug- and placebo-treated neurotic outpatients. Pretreatment levels of manifest anxiety, clinical improvement, and side reactions.
    Rickels K; Downing RW
    Arch Gen Psychiatry; 1967 Mar; 16(3):269-72. PubMed ID: 6021472
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical observations on the action of the new benzodiazepine, B 5833 (camazepm)].
    Visentin B; Mattiuzzi D; Tallone G
    Clin Ter; 1974 Mar; 69(4):353-9. PubMed ID: 4844933
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical observation of a new anxiolytic phenothiazine derivative].
    Vieira JC
    Hospital (Rio J); 1970 Oct; 78(4):1147-53. PubMed ID: 5313973
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparison of neuroleptics, antidepressive drugs and anxiolytic agents in minor nervous diseases].
    Bratfos O
    Tidsskr Nor Laegeforen; 1976 Sep; 96(25):1331-2. PubMed ID: 9708
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic trial with thiothixene in emotional disorders. Controlled study and use of new forms of evaluation].
    Butler Blacker A
    Rev Neuropsiquiatr; 1969 Jun; 32(2):120-34. PubMed ID: 4937589
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ataractic treatment in psychiatry and general medicine. Review of preparations. 9].
    Hertrich O
    Fortschr Med; 1983 Oct; 101(40):1828-30. PubMed ID: 6642389
    [No Abstract]   [Full Text] [Related]  

  • 14. [A new treatment in current psychiatric practice: Sedalium].
    Dubois JC; Dacharry JC; Demoures JM
    Ann Med Psychol (Paris); 1970 Feb; 1(2):276-93. PubMed ID: 5420925
    [No Abstract]   [Full Text] [Related]  

  • 15. [Preliminary note on the action of thiothixen in psychoneurotic patients].
    Migliarese L
    Fracastoro; 1968; 61(2):187-90. PubMed ID: 5704051
    [No Abstract]   [Full Text] [Related]  

  • 16. [Extension of therapeutic possibilities by a new tranquilizer].
    Leube H
    Arzneimittelforschung; 1968 Dec; 18(12):1566-8. PubMed ID: 5756250
    [No Abstract]   [Full Text] [Related]  

  • 17. Serax and solacen.
    Med Lett Drugs Ther; 1965 Nov; 7(23):93-4. PubMed ID: 5319420
    [No Abstract]   [Full Text] [Related]  

  • 18. [Neuroses and their related diseases and tranquilizing agents].
    Suwa N
    Naika; 1967 Jun; 19(6):1271-5. PubMed ID: 6079610
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of acetophenazine in office practice.
    Cook RW
    Int J Neuropsychiatry; 1965 Dec; 1(6):605-7. PubMed ID: 5894976
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of an inhibition-counteracting agent in the adolescent].
    Danjoux J; Moron P
    Neuropsychiatr Enfance Adolesc; 1979 Jun; 27(6):293-7. PubMed ID: 530420
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.